Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

1995

Klampfer L, Chen-Kiang S, Vilcek J. Activation of the TSG-6 gene by NF-IL6 requires two adjacent NF-IL6 binding sites. J Biol Chem. 1995;270(8):3677-82.

Knowles DM, Cesarman E, Chadburn A, Frizzera G, Chen J, Rose EA, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood. 1995;85(2):552-65.

Kastrinakis WV, Ramchurren N, Rieger KM, Hess DT, Loda M, Steele G, et al. Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression. Oncogene. 1995;11(4):647-52.

Gordon FD, Anastopoulos H, Khettry U, Loda M, Jenkins RL, Lewis WD, et al. Hepatitis C infection: a rare cause of fulminant hepatic failure. Am J Gastroenterol. 1995;90(1):117-20.

Magro CM, Crowson AN. Cutaneous manifestations of Behçet's disease. Int J Dermatol. 1995;34(3):159-65.

Schettino EW, Newcomb EW, Potmesil M, Inghirami G, Casali P. Clonal analysis of IgM+ CD5+ CLL B cells. Ann N Y Acad Sci. 1995;764:485-91.

Magro CM, Crowson AN, Peeling R. Vasculitis as the basis of cutaneous lesions in Reiter's disease. Hum Pathol. 1995;26(6):633-8.

Galaktionov K, Lee AK, Eckstein J, Draetta G, Meckler J, Loda M, et al. CDC25 phosphatases as potential human oncogenes. Science. 1995;269(5230):1575-7.

Chadburn A, Cesarman E, Liu YF, Addonizio L, Hsu D, Michler RE, et al. Molecular genetic analysis demonstrates that multiple posttransplantation lymphoproliferative disorders occurring in one anatomic site in a single patient represent distinct primary lymphoid neoplasms. Cancer. 1995;75(11):2747-56.

Lin J, Gettys TW, Qin L, Chavin KD, Yang Q, Ding Y, et al. Increased cAMP and cAMP-dependent protein kinase activity mediate anti-CD2 induced suppression of anti-CD3-driven interleukin-2 production and CD25 expression. Pathobiology. 1995;63(4):175-87.